Ann: Mesoblast Completes Placement and Entitlement Offer, page-124

Another item a partnership would resolve; the debt / loan situation …. one would hope that Mesoblast don’t need to renegotiate their loan situation if a partnership deal is on the table ?

Oaktree don’t have the best reputation so I guess one positive after yesterday is that if Oaktree did act in bad faith and call in the loan now at least we would have enough to cover it and still have funds left over, albeit very limited …..

A CLBP partnership seems the most likely next step at the moment given the phase 3 trial is ‘underway’ now …..

@otherperspective I agree that with all the FDA regulatory progress / updates recently, Mesoblast should have been able to sell the overhang at a premium …. I too am disappointed that they weren’t able to but what is done is done I guess and of course it’s just another poorly executed CR with an excessive dilution effect that us LT holders have had to endure (sadly).

GLTAH